Technical Analysis for TNDM - Tandem Diabetes Care, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 47.37 | 7.49% | 3.30 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Stochastic Reached Overbought | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Wide Bands | Range Expansion | 7.49% | |
| NR7 | Range Contraction | 7.83% | |
| Stochastic Reached Overbought | Strength | 7.83% | |
| Wide Bands | Range Expansion | 7.83% |
| Alert | Time |
|---|---|
| New 52 Week High | about 18 hours ago |
| Up 1 ATR | about 20 hours ago |
| Up 5% | about 20 hours ago |
| Up 3% | about 22 hours ago |
| 60 Minute Opening Range Breakout | about 22 hours ago |
Get a Trading Sidekick!
- Earnings date: 05/02/2024
Tandem Diabetes Care, Inc. Description
Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes. The company's products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides users, their caregivers, and their healthcare providers a fast, easy, and visual way to display therapy management data from the pump and supported blood glucose meters. It sells its products in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Telehealth Telemedicine Healthcare Providers Medical Device Glucose Insulin Endocrine System Diabetes Mellitus Endocrinology Diabetes Management Caregiver Diabetes Care Infusion Set Diabetes Mellitus Type 1 Glucose Meter Insulin Delivery Insulin Dependent Diabetes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 47.44 |
| 52 Week Low | 13.82 |
| Average Volume | 1,738,217 |
| 200-Day Moving Average | 26.40 |
| 50-Day Moving Average | 34.74 |
| 20-Day Moving Average | 38.93 |
| 10-Day Moving Average | 43.47 |
| Average True Range | 2.40 |
| RSI (14) | 74.23 |
| ADX | 37.21 |
| +DI | 40.69 |
| -DI | 13.80 |
| Chandelier Exit (Long, 3 ATRs) | 40.24 |
| Chandelier Exit (Short, 3 ATRs) | 37.32 |
| Upper Bollinger Bands | 49.26 |
| Lower Bollinger Band | 28.60 |
| Percent B (%b) | 0.91 |
| BandWidth | 53.08 |
| MACD Line | 3.38 |
| MACD Signal Line | 2.79 |
| MACD Histogram | 0.594 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 52.19 | ||||
| Resistance 3 (R3) | 51.67 | 49.56 | 51.38 | ||
| Resistance 2 (R2) | 49.56 | 48.33 | 49.81 | 51.11 | |
| Resistance 1 (R1) | 48.46 | 47.57 | 49.01 | 48.98 | 50.85 |
| Pivot Point | 46.35 | 46.35 | 46.62 | 46.60 | 46.35 |
| Support 1 (S1) | 45.25 | 45.12 | 45.80 | 45.77 | 43.89 |
| Support 2 (S2) | 43.14 | 44.36 | 43.39 | 43.63 | |
| Support 3 (S3) | 42.04 | 43.14 | 43.36 | ||
| Support 4 (S4) | 42.56 |
